What is it about?
This is a meta-analysis estimating the rates of overall and IPMN-related deaths among patient with IPMNs with morphological criteria suggesting absolute or relative indication for surgery who have not been operated for any reason (e.g. age or comorbidities, patients' choice, physicians' recommendation).
Featured Image
Why is it important?
Pooling together all available evidence, we have found that in series of patients with high-risk IPMNs who were observed instead of being referred for surgery, mortality due to background conditions was three times superior than that related to IPMNs' progression and invasion. This was particularly true for branch-duct IPMNs, while main-duct IPMNs carry a 6-fold higher rate of disease-specific mortality. These data support a new perspective in the management of IPMN patients, beyond a static "to operate or not" strategy based on morphological criteria: to never start surveillance in unfit-for-surgery patients and to continue an intensive observation even in patients with high-risk IPMNs until their personalised risk/benefit ratio is in favour of surgery.
Perspectives
Read the Original
This page is a summary of: Meta-analysis of mortality in patients with high-risk intraductal papillary mucinous neoplasms under observation, British Journal of Surgery, February 2018, Wiley,
DOI: 10.1002/bjs.10768.
You can read the full text:
Resources
Contributors
The following have contributed to this page